価値に基づくヘルスケアの世界市場

価値に基づくヘルスケアの世界市場は2030年までに251億米ドルに達する見込み

2024年に101億米ドルと推定される価値に基づくヘルスケアの世界市場は、2024年から2030年にかけてCAGR 16.4%で成長し、2030年には251億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるPay for Performanceは、CAGR 15.3%を記録し、分析期間終了時には58億米ドルに達すると予測されます。患者中心の医療施設（Patient-centered Medical Home）分野の成長率は、分析期間のCAGRで14.0％と推定されます。

米国市場は28億米ドル、中国はCAGR 21.4％で成長すると予測

米国の価値に基づくヘルスケア市場は、2024年に28億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに54億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは21.4%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ12.2%と14.6%と予測されています。欧州では、ドイツがCAGR約13.0％で成長すると予測されています。

世界の「価値に基づくヘルスケア」市場- 主要動向と促進要因のまとめ

伝統的ヘルスケアモデルがバリューベースケアに移行しつつある理由

世界のヘルスケア業界は大きな変革期を迎えており、プロバイダーがサービスごとに報酬を受け取るボリュームベースのモデルから、患者のアウトカムやケアの質に連動して報酬が支払われる価値に基づくヘルスケア（VBHC）へと軸足を移しつつあります。このシフトは、ヘルスケアコストの持続不可能な上昇、ケア提供の分断化、そしてフィーフォー・サービス・システムにおける患者のアウトカムが最適でないことに起因しています。バリュー・ベース・ケアは、提供されるサービスの量ではなく、効率性、連携、測定可能な健康改善に対してプロバイダーに報酬を与えることで、インセンティブを再調整するものです。民間保険会社や公的医療システムを含む支払者は、医療提供者に責任を負わせるために、一括支払い、共有貯蓄プログラム、アウトカムベースの契約を採用するようになってきています。この進化は、慢性疾患の蔓延、人口の高齢化、アウトカムの追跡とリスク層別化を可能にするデジタルの進歩によっても拍車がかかっています。VBHCは、パーソナライズされたケア・パスウェイを通じて患者に力を与え、医療提供者の説明責任を強化し、システムの効率性を促進するもので、世界中の次世代ヘルスケア改革の取り組みの要となっています。

デジタル技術は価値に基づくヘルスケアの台頭をどのように可能にしていますか？

テクノロジーは価値に基づくヘルスケアのバックボーンであり、リアルタイムのデータ共有、アウトカム測定、大規模な患者エンゲージメントを可能にします。電子カルテ（EHR）、遠隔医療、モバイルヘルスアプリケーションは、協調的、継続的、データ駆動型のケアを促進する上で不可欠なツールとなっています。高度な分析プラットフォームは、ビッグデータを活用して患者のリスクを予測し、慢性疾患の進行を監視し、治療計画を個別化します。人工知能（AI）は、大量の臨床データや請求データを分析し、ケアギャップを特定し、エビデンスに基づく介入を推奨するために利用されています。遠隔患者モニタリング（RPM）機器により、特に糖尿病、高血圧、心不全などのハイリスク患者に対するプロアクティブなケア管理が可能になります。医療ITシステム間の相互運用性も向上しており、複数の利害関係者（病院、支払者、プライマリ・ケア医、専門医）が効果的に連携しやすくなっています。このようなデジタル機能は、ケアの質向上をサポートするだけでなく、多様なヘルスケアシステムにおいて、パフォーマンスベースの支払いモデルを実行可能かつスケーラブルなものにします。

利害関係者の連携と政策改革は普及を促進できるか？

価値に基づくヘルスケアへの移行は、政府、支払者、医療提供者、製薬会社、そして患者といった多様な利害関係者が、共通の健康目標に向けて一致団結することにかかっています。政策立案者は、VBHC導入を支援する規制やインセンティブを制定することで、重要な役割を果たしています。米国では、Medicare Shared Savings ProgramやAccountable Care Organizations（ACOs）のようなイニシアチブが、コスト削減と質の向上において早くから成功を収めています。同様に、スウェーデン、オランダ、シンガポールなどの国々も、VBHCの原則を国家保健戦略に組み込んでいます。製薬会社や医療機器メーカーも、償還を売上単位ではなく、実際の効果に結びつける価値ベースの契約を受け入れています。雇用主や保険会社は、長期的なコストを管理するために、対象集団に対してアウトカムに基づく医療を求めています。患者の支持はますます強くなり、透明性、個別化されたケア、測定可能なアウトカムを求めています。抵抗勢力を克服し、バリュー・ベースの枠組みをニッチではなくノーマルなものとして確立するためには、教育、信頼構築、データの透明性が引き続き極めて重要です。

価値に基づくヘルスケア市場の拡大成長の原動力は？

価値に基づくヘルスケア市場の成長は、ヘルスケアシステムの非効率性、支払者のイノベーション、患者の期待の変化に根ざしたいくつかの要因によってもたらされています。医療費の増加は、患者のアウトカムの向上に比例しないため、利害関係者はより持続可能な、パフォーマンス連動型のケアモデルを求めざるを得なくなっています。慢性疾患と多疾病の蔓延は、長期的で協調的なケアを必要とし、それはVBHCの枠組みを通じてよりよくサポートされます。デジタルヘルス技術の導入が進むと、健康アウトカムとコスト指標の正確な測定が可能になり、バリューベースの償還が現実的になります。雇用主や民間支払者は、予防医療と長期的な健康アウトカムに焦点を当てた価値ベースの保険設計を提唱しており、それによって支払者側の需要を促進しています。一方、ペイシェントジャーニーに参加する患者も増えており、コストの透明性、治療効果、個別化された体験など、VBHCが提供する仕組みのすべてを期待しています。政府の改革と世界・ヘルス・イニシアチブは、政策支援、パイロット・プログラム、国際的なベスト・プラクティスの共有を通じて、バリュー・ベースのアプローチをさらに制度化しています。こうした動きが強まるにつれ、VBHCは理論的なモデルから、世界規模でヘルスケアの提供を再定義する有力なパラダイムへと移行しつつあります。

セグメント

モデル（ペイ・フォー・パフォーマンス、患者中心のメディカルホーム、シェアード・セービング、シェアード・リスク、バンドル・ペイメント、キャピテーション・モデル）、支払者（メディケア＆メディケア・アドバンテージ、メディケイド、コマーシャル）、プロバイダー（在宅ヘルスケア、施設ケア、セルフケア、病院療法）

調査対象企業の例（注目の43社）

• Aetna Inc.
• Anthem, Inc.
• Athenahealth
• Baker Tilly US, LLP
• Better Health Group
• Blue Cross and Blue Shield of Minnesota
• Cardinal Health
• Change Healthcare
• Cigna Healthcare
• Curation Health
• Deloitte
• Humana
• Kaiser Permanente
• Lumeris
• McKesson Corporation
• MVP Health Care
• Navvis Healthcare
• NXGN Management, LLC
• Signify Health, Inc.
• UnitedHealth Group

AI統合

私たちは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Value-based Healthcare Market to Reach US$25.1 Billion by 2030

The global market for Value-based Healthcare estimated at US$10.1 Billion in the year 2024, is expected to reach US$25.1 Billion by 2030, growing at a CAGR of 16.4% over the analysis period 2024-2030. Pay for Performance, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$5.8 Billion by the end of the analysis period. Growth in the Patient-centered Medical Home segment is estimated at 14.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.8 Billion While China is Forecast to Grow at 21.4% CAGR

The Value-based Healthcare market in the U.S. is estimated at US$2.8 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$5.4 Billion by the year 2030 trailing a CAGR of 21.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.2% and 14.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.0% CAGR.

Global "Value-Based Healthcare" Market - Key Trends & Drivers Summarized

Why Is the Traditional Healthcare Model Giving Way to Value-Based Care?

The global healthcare industry is undergoing a significant transformation, pivoting away from volume-based models-where providers are paid per service-to value-based healthcare (VBHC), where payments are linked to patient outcomes and care quality. This shift is driven by the unsustainable rise in healthcare costs, fragmented care delivery, and suboptimal patient outcomes in fee-for-service systems. Value-based care realigns incentives by rewarding providers for efficiency, coordination, and measurable health improvements rather than the sheer quantity of services delivered. Payers, including private insurers and public health systems, are increasingly adopting bundled payments, shared savings programs, and outcome-based contracts to hold providers accountable. This evolution is also spurred by chronic disease prevalence, aging populations, and digital advancements that enable outcome tracking and risk stratification. VBHC empowers patients through personalized care pathways, enhances provider accountability, and fosters systemic efficiency, making it a cornerstone of next-generation healthcare reform efforts worldwide.

How Are Digital Technologies Enabling the Rise of Value-Based Healthcare?

Technology is the backbone of value-based healthcare, enabling real-time data sharing, outcome measurement, and patient engagement at scale. Electronic health records (EHRs), telemedicine, and mobile health applications have become essential tools in facilitating coordinated, continuous, and data-driven care. Advanced analytics platforms leverage big data to predict patient risk, monitor chronic disease progression, and personalize treatment plans. Artificial intelligence (AI) is being used to analyze large volumes of clinical and claims data, identify care gaps, and recommend evidence-based interventions. Remote patient monitoring (RPM) devices allow for proactive care management, particularly for high-risk patients with conditions like diabetes, hypertension, and heart failure. Interoperability among health IT systems is also improving, making it easier for multiple stakeholders-hospitals, payers, primary care physicians, and specialists-to collaborate effectively. These digital capabilities not only support care quality improvement but also make performance-based payment models viable and scalable across diverse healthcare systems.

Can Stakeholder Alignment and Policy Reform Drive Widespread Adoption?

The transition to value-based healthcare hinges on the collective alignment of diverse stakeholders-governments, payers, providers, pharmaceutical companies, and patients-toward shared health goals. Policymakers are playing a critical role by enacting regulations and incentives that support VBHC adoption. In the U.S., initiatives like the Medicare Shared Savings Program and Accountable Care Organizations (ACOs) have demonstrated early success in cost reduction and quality enhancement. Similarly, countries like Sweden, the Netherlands, and Singapore have incorporated VBHC principles into national health strategies. Pharmaceutical and medical device companies are also embracing value-based agreements that tie reimbursement to real-world effectiveness, rather than unit sales. Employers and insurers are demanding outcome-based care for their covered populations to manage long-term costs. Patient advocacy is growing stronger, demanding transparency, personalized care, and measurable outcomes. Education, trust-building, and data transparency remain crucial for overcoming resistance and establishing value-based frameworks as a norm rather than a niche.

What Is Fueling the Expansive Growth in the Value-Based Healthcare Market?

The growth in the value-based healthcare market is driven by several factors rooted in healthcare system inefficiencies, payer innovations, and changing patient expectations. Rising healthcare expenditures-without proportional gains in patient outcomes-have compelled stakeholders to seek more sustainable, performance-linked care models. The proliferation of chronic illnesses and multimorbidity requires long-term, coordinated care, which is better supported through VBHC frameworks. Increasing adoption of digital health technologies enables accurate measurement of health outcomes and cost metrics, making value-based reimbursement practical. Employers and private payers are advocating for value-based insurance designs that focus on preventive care and long-term health outcomes, thereby driving demand from the payer side. Meanwhile, patients are becoming more involved in their healthcare journeys, expecting cost transparency, treatment efficacy, and personalized experiences-all of which VBHC is structured to deliver. Government reforms and global health initiatives are further institutionalizing value-based approaches through policy support, pilot programs, and international best practice sharing. As these dynamics intensify, VBHC is transitioning from a theoretical model into a dominant paradigm poised to redefine healthcare delivery on a global scale.

SCOPE OF STUDY:

The report analyzes the Value-based Healthcare market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Models (Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment, Capitation Models); Payer (Medicare & Medicare Advantage, Medicaid, Commercial); Providers (Home Healthcare, Institutional Care, Self-Care, Hospital Therapy)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

• Aetna Inc.
• Anthem, Inc.
• Athenahealth
• Baker Tilly US, LLP
• Better Health Group
• Blue Cross and Blue Shield of Minnesota
• Cardinal Health
• Change Healthcare
• Cigna Healthcare
• Curation Health
• Deloitte
• Humana
• Kaiser Permanente
• Lumeris
• McKesson Corporation
• MVP Health Care
• Navvis Healthcare
• NXGN Management, LLC
• Signify Health, Inc.
• UnitedHealth Group

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Value-based Healthcare - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Shift from Volume to Outcomes-Based Models Strengthens Business Case for Value-Based Healthcare
  • Emphasis on Patient-Centered Care Expands Addressable Markets for Digital Health Platforms
  • Chronic Disease Management Programs Drive Adoption of Outcome-Oriented Models
  • Government Healthcare Reforms Generate Demand for Quality and Cost Optimization
  • Integration of Wearables and Remote Monitoring Technologies Spurs Real-Time Outcome Tracking
  • Advanced Data Analytics and AI Throw the Spotlight on Predictive Healthcare Solutions
  • Focus on Reducing Hospital Readmissions Sustains Demand for Coordinated Care Models
  • Health Equity and Access Challenges Create Opportunities for Value-Driven Outreach Models
  • Physician Performance and Quality Metrics Enhance Accountability and Propel Payment Shifts
  • Interoperability and Health IT Infrastructure Limitations Pose Adoption Barriers
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Value-based Healthcare Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Value-based Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Value-based Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Value-based Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Pay for Performance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Pay for Performance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Pay for Performance by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Patient-centered Medical Home by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Patient-centered Medical Home by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Patient-centered Medical Home by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Shared Savings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Shared Savings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Shared Savings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Shared Risk by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Shared Risk by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Shared Risk by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Bundled Payment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Bundled Payment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Bundled Payment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Capitation Models by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Capitation Models by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Capitation Models by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Home Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Home Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Home Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Institutional Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Institutional Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Institutional Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Self-Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Self-Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Self-Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Hospital Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Hospital Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Hospital Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Medicare & Medicare Advantage by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Medicare & Medicare Advantage by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Medicare & Medicare Advantage by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Medicaid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Medicaid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Medicaid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Commercial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Commercial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Commercial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Value-based Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 44: USA Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• JAPAN
  • Value-based Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• CHINA
  • Value-based Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 71: China Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• EUROPE
  • Value-based Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Value-based Healthcare by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Value-based Healthcare by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Value-based Healthcare by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• FRANCE
  • Value-based Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 92: France Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: France 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 95: France Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: France 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 98: France Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: France Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: France 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• GERMANY
  • Value-based Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Germany 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Germany 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 107: Germany Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Germany Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Germany 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Italy 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Italy 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 116: Italy Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Italy Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Italy 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Value-based Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 119: UK Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: UK 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 122: UK Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: UK 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 125: UK Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: UK Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: UK 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Spain 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Spain 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 134: Spain Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Spain Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Spain 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Russia 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Russia 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 143: Russia Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Russia Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Russia 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Rest of Europe Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Rest of Europe 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Value-based Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Value-based Healthcare by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Value-based Healthcare by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Value-based Healthcare by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Asia-Pacific Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Asia-Pacific 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Value-based Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Australia 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Australia 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 173: Australia Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Australia Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Australia 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• INDIA
  • Value-based Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 176: India Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: India 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 179: India Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: India 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 182: India Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: India Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: India 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: South Korea 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: South Korea 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 191: South Korea Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: South Korea Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: South Korea 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Asia-Pacific Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Value-based Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Value-based Healthcare by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Value-based Healthcare by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Value-based Healthcare by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Latin America 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 212: Latin America Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Latin America Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Latin America 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Argentina 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Argentina 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 221: Argentina Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Argentina Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Argentina 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Brazil 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Brazil 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 230: Brazil Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Brazil Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Brazil 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Mexico 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Mexico 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 239: Mexico Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Mexico Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Mexico 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Latin America Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Latin America 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Value-based Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Value-based Healthcare by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Value-based Healthcare by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Value-based Healthcare by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Middle East 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 260: Middle East Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Middle East Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Middle East 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Iran 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Iran 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 269: Iran Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Iran Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Iran 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Israel 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Israel 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 278: Israel Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Israel Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Israel 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Saudi Arabia Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Saudi Arabia 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: UAE 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: UAE 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 296: UAE Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: UAE Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: UAE 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Middle East Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Middle East 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030
• AFRICA
  • Value-based Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Value-based Healthcare by Models - Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Africa 15-Year Perspective for Value-based Healthcare by Models - Percentage Breakdown of Value Sales for Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment and Capitation Models for the Years 2015, 2025 & 2030
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Value-based Healthcare by Providers - Home Healthcare, Institutional Care, Self-Care and Hospital Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Africa 15-Year Perspective for Value-based Healthcare by Providers - Percentage Breakdown of Value Sales for Home Healthcare, Institutional Care, Self-Care and Hospital Therapy for the Years 2015, 2025 & 2030
  • TABLE 314: Africa Recent Past, Current & Future Analysis for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Africa Historic Review for Value-based Healthcare by Payer - Medicare & Medicare Advantage, Medicaid and Commercial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Africa 15-Year Perspective for Value-based Healthcare by Payer - Percentage Breakdown of Value Sales for Medicare & Medicare Advantage, Medicaid and Commercial for the Years 2015, 2025 & 2030

IV. COMPETITION